Assisting Obsessive Compulsive Disorder (OCD) Patients With Discontinuing Long-term Serotonin Reuptake Inhibitors (SRIs)
Status: | Completed |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 6/16/2018 |
Start Date: | May 2014 |
End Date: | January 2018 |
Discontinuation of Long-term SRIs in Obsessive Compulsive Disorder
This study will address questions of fundamental clinical significance including: (1) whether
OCD patients maintained on long term SRIs can be discontinued without symptom exacerbation,
(2) whether trans-diagnostic cognitive-behavioral treatment will reduce worsening following
discontinuation compared to Taper and Monitoring, and (3) whether predictors of successful
SRI discontinuation can be identified.
OCD patients maintained on long term SRIs can be discontinued without symptom exacerbation,
(2) whether trans-diagnostic cognitive-behavioral treatment will reduce worsening following
discontinuation compared to Taper and Monitoring, and (3) whether predictors of successful
SRI discontinuation can be identified.
Inclusion Criteria:
1. 18 or older
2. Presence of mild to moderate OCD symptoms
3. Patient's treating clinician agrees that SRI discontinuation is clinically appropriate
4. Adequate trial of SRI (≥10 weeks) in the current treatment episode
5. Maintenance on SRI dose that has not increased due to significant clinical worsening
in the two years prior to enrollment
6. English speaking
Exclusion Criteria:
1. Clinically significant suicidality or a suicide attempt within the past year
2. Presence of any clinical features warranting a higher level of care (partial or
inpatient hospitalization)
3. Current or recent (past 6 months) alcohol or drug dependence or abuse
4. Current or past psychotic disorder or bipolar disorder
5. Moderate to severe depression, as indicated by a Hamilton Rating Scale for Depression
(HRSD) (17-item) ≥ 14 or recent major depressive episode (past 6 months)
6. History of severe OCD (YBOCS ≥ 28)
7. Prior adverse experience with SRI discontinuation
8. Primary compulsive hoarding
9. Cognitive impairment that would interfere with study participation
10. Concomitant psychosocial treatment w/ proven efficacy in the treatment of OCD
11. Previous adequate trial of exposure-based treatment (e.g., history of 12 or more
sessions) in past 5 years
12. Use of non-SRI psychotropic medications for OCD in the 3 months prior to enrollment.
We found this trial at
1
site
345 Blackstone Blvd
Providence, Rhode Island 02906
Providence, Rhode Island 02906
(401) 455-6200
Principal Investigator: Christina L Boisseau, Ph.D.
Butler Hospital Founded in 1844, Butler Hospital is the state's only non-profit, free-standing psychiatric hospital...
Click here to add this to my saved trials